BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21543370)

  • 1. PPIs: too much of a good thing?
    Drug Ther Bull; 2011 May; 49(5):49. PubMed ID: 21543370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proton pump inhibitors are suspected of serious adverse effects. More cautious prescribing should be considered and on correct indications].
    Backman L; Schmidt D; Vitols S
    Lakartidningen; 2013 Apr 17-23; 110(16):828-31. PubMed ID: 23717929
    [No Abstract]   [Full Text] [Related]  

  • 3. The dangers of proton pump inhibitor therapy.
    Owen C; Marks DJ; Banks M
    Br J Hosp Med (Lond); 2014 Jul; 75(7):C108-12. PubMed ID: 25152941
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and medical management of Clostridium difficile infection.
    Shannon-Lowe J; Matheson NJ; Cooke FJ; Aliyu SH
    BMJ; 2010 Mar; 340():c1296. PubMed ID: 20228142
    [No Abstract]   [Full Text] [Related]  

  • 5. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
    Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
    Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship among proton pump inhibitors, bone disease and fracture.
    Targownik LE; Leslie WD
    Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued high use of PPIs despite C. difficile risk.
    Brown C
    CMAJ; 2014 Dec; 186(18):1350. PubMed ID: 25384647
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton pump inhibitors: fractures (continued). Beware long-term use.
    Prescrire Int; 2011 Oct; 20(120):241. PubMed ID: 21970088
    [No Abstract]   [Full Text] [Related]  

  • 12. PPIs and fracture risk.
    Med Lett Drugs Ther; 2013 Feb; 55(1410):15-6. PubMed ID: 23459458
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitors and fractures? Beware long-term use.
    Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19885973
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
    Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
    Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.
    Min JH; Kim YS
    Gut Liver; 2016 Jul; 10(4):493-4. PubMed ID: 27377737
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 17. Proton Pump Inhibitor Use in Older Adults: Long-Term Risks and Steps for Deprescribing.
    Pezeshkian S; Conway SE
    Consult Pharm; 2018 Sep; 33(9):497-503. PubMed ID: 30185290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential risks associated with long-term PPI use].
    Kamiya T
    Nihon Rinsho; 2016 Aug; 74(8):1387-1391. PubMed ID: 30562448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and bone fractures?
    Laine L
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S21-6. PubMed ID: 19262543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.